Dr Raphael Pfeffer CV Dr. M. Raphael Pfeffer Director of Oncology ...
Dr Raphael Pfeffer CV Dr. M. Raphael Pfeffer Director of Oncology ...
Dr Raphael Pfeffer CV Dr. M. Raphael Pfeffer Director of Oncology ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Dr</strong> <strong>Raphael</strong> <strong>Pfeffer</strong> <strong>CV</strong> 1<strong>Dr</strong>. M. <strong>Raphael</strong> <strong>Pfeffer</strong><strong>Director</strong> <strong>of</strong> <strong>Oncology</strong> InstituteAssuta Medical CenterTel Aviv, Israelד"ר רפאל פפרמנהל המכון האונקולוגיבית חולים אסותאתל אביבניסיון קליני ואקדמי0891-08910891-0891ו0891-0899שרות צבאי.0881-0881 ,0891-08990899-0881מתמחה במכון האונקולוגי, בית חולים הדסה, עין כרם, ירושלים.רופא בכיר יחידה לרדיותרפיה, מכון האונקולוגי., בית חולים הדסה.השתלמות קלינית ומחקרית ברדיותרפיה בדנה פרבר, בית חולים לילדים ובית חולים בריגהם(., Harvard Joint Center for Radiotherapy,0881-0881,0881-0101מרצה אורח, מחלקה לרדיותרפיה, בית חולים של אוניברסיטת מישיגן, אן ארבור.מנהל היחידה לרדיותרפיה, מרכז רפואי שיבא, תל השומר.בוסטון ארה"ב. )ביח חוליםמאז 0111, מרצה בכיר, פקולטה לרפואה, אוניברסיטת תל אביב.ועדות וכו"מאזמאז, 0880,0110, 0888-0110,0111-01110110חבר ועדת הבחינות באונקולוגיה קלינית ורדיותרפיה.יו"ר תת-ועדה ברדיותרפיה, ועדת הבחינות באונקולוגיה קלינית ורדיותרפיהיו"ר ועדת ביקורת של האיגוד האונקולוגי.יו"ר החוג לרדיותרפיה., חבר בוועדה המארגנת כנס עולמי שלילי של ISRS.International Stereotactic Radiosurgery Society.0110-01010111-01000101מאזמארגן ואחראי על קורס ארצי בפיסיקה קרינתית למתמחים.מארגן ואחראי על קורס ארצי בהדמיה לרדיותרפיה.יו"ר כנס ISCORT,0118חבר בASTRO Multidisciplinary QA SubcommitteeReviewer:פרסומים מדעיים:יותר מInternational Journal Radiation <strong>Oncology</strong> Biology and PhysicsAmerican Journal <strong>of</strong> Clinical <strong>Oncology</strong>Neoplasia91פרסומים בספרות הרפואית.
<strong>Dr</strong> <strong>Raphael</strong> <strong>Pfeffer</strong> <strong>CV</strong> 21. <strong>Pfeffer</strong> MR, Sulkes A, Biran S.Treatment <strong>of</strong> advanced s<strong>of</strong>t tissue sarcomas with a modified CYVADIC protocol.<strong>Oncology</strong> 41:308-313, 1984.2. Siegal T, <strong>Pfeffer</strong> MR, Catane R, Sulkes A, Gomori MJ & Fuks Z.Successful chemotherapy <strong>of</strong> recurrent intracranial germinoma.Neurology 33:631-633, 1983.3. <strong>Pfeffer</strong> MR, Sulkes A, Yablonski-Peretz T, Fuks Z, Catane R.Phase I study <strong>of</strong> the combination <strong>of</strong> Mitomycin C and oral metronidazole.Cancer Treatment Reports 68:1191-1192, 1984.4. Rabinovitz R, <strong>Pfeffer</strong> MR, Anteby SO.Surgical treatment <strong>of</strong> pseudomyxoma peritonei.Harefuah 108:238-239. 1985.5. Sulkes A, Gez E, <strong>Pfeffer</strong> MR, Catane R, Isaacson R, Biran S.Adriamycin, Vinblastine and Mitomycin C as a second line chemotherapy in advanced breastcancer.Cancer Chemotherapy and Pharmacol. 18:162-167, 1986.6. Siegal T, <strong>Pfeffer</strong> MR, Steiner I.Antibiotic therapy for infected Ommaya reservoir system.Neurosurgery 22:97-100. 19877. <strong>Pfeffer</strong> MR, Wygoda M, Siegal T.Leptomeningeal metastases: treatment results in 98 consecutive patients.Israel J <strong>of</strong> Medical Sciences. 24:611-618. 1988.8. <strong>Pfeffer</strong> MR, Sulkes A, Biran S.Cyclophosphamide, Adriamycin, DTIC, and vincristine with methotrexate in the treatment <strong>of</strong>advanced s<strong>of</strong>t tissue sarcomas.Israel J Med Sci. 24:599-603, 1988.9. Weshler Z, Gez E, <strong>Pfeffer</strong> MR, Ben-Yosef R, Loewenthal E, Fuks Z.Continuous course <strong>of</strong> megavoltage radiotherapy for carcinoma <strong>of</strong> the prostate.Israel J Med Sci, 24:580-583, 1988.10. Teicher BA, Herman TS, <strong>Pfeffer</strong> MR, Alvarez-Sotomayer EA & Khandekar VS.Interaction <strong>of</strong> PtCl4(fast black)2 with hyperthermia.Cancer Res. 49:6208-6213, 1989.11. Herman TS, Jochelson MS, Teicher BA, Scott PJ, Hansen J, <strong>Pfeffer</strong> MR, Clark JR, Gelwan LE, Molnar-GriffinBJ, Fraser SM, Svennson G, Bornstein BA, & Coleman CN.A phase I-II trial <strong>of</strong> cisplatin, hyperthermia and radiation in patients with locally advancedmalignancies.Int J Radiat Oncol Biol Phys. 17:1273-1279, 1989.12. <strong>Pfeffer</strong> MR, Teicher BA, Holden SA, Al-Achi & Herman TS.The interaction <strong>of</strong> cisplatin plus etoposide with radiation ± hyperthermia.Int J Radiat Oncol Biol Phys. 19:1439-1447, 1990.
<strong>Dr</strong> <strong>Raphael</strong> <strong>Pfeffer</strong> <strong>CV</strong> 313. Herman TS, Teicher BA, <strong>Pfeffer</strong> MR, Khandekar VS & Korbut TT.Interaction with hyperthermia <strong>of</strong> PtCl4(nile blue)2 and PtCl4(neutral red)2.Cancer Res. 50:3826-3831, 1990.14. Teicher BA, Herman TS, Holden SA, Wang Y, <strong>Pfeffer</strong> MR, Crawford JM & Frei E III.Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo.Science 247:1457-1461, 1990.15. Herman TS, Teicher BA, Holden SA, <strong>Pfeffer</strong> MR & Jones.Addition <strong>of</strong> 2-nitroimidazole radiosensitizers to trimodality therapy Cisdiammine-dichloro -platinum II /hyperthermia/ radiation) in the murine FSaIIC fibrosarcoma.Cancer Res. 50:2734-2740, 1990.16. Herman TS, Teicher BA, <strong>Pfeffer</strong> MR, Khandekar VS, Chapman RM, Kalick GS & Rabow A.Effect <strong>of</strong> acidic pH on radiosensitization <strong>of</strong> FSaIIC cells in vitro by misonidazole, etanidazole orCisdiamminedichloroplatinum(II).Radiat Res. 124:28-33, 1990.17. Herman TS, Teicher BA, <strong>Pfeffer</strong> MR, Khandekar VS, Alvarez- Sotomayor E.Interaction <strong>of</strong> platinum complexes <strong>of</strong> thiazine and xanthene dyes with hyperthermia. CancerChemother Pharmacol 26:127-134, 1990.18. Herman TS, Teicher BA, <strong>Pfeffer</strong> MR, Khandekar VS.Interaction with hyperthermia <strong>of</strong> platinum complex <strong>of</strong> triaminotryphenyl-methane dyes.Int J Hyperthermia 6:629-639, 1990.19. Weshler Z, Breuer R, Or R, Naparstak E, <strong>Pfeffer</strong> MR, Loewenthal E, Slavin S.Interstitial pneumonitis after total body irradiation: effect <strong>of</strong> partial lung shielding.Br J Haematol 74:61-61, 1990.20. Teicher BA, <strong>Pfeffer</strong> MR, Alvarez-Sotomayer EA, & Herman TS.Schedule dependent tumor growth delay, DNA cross-linking and pharmacokinetic parametersin target tissues with Cisdiammine-dichloroplatinum(II) and etanidazole with or withouthyperthermia or radiation.Int J Hyperthermia 7:773-784, 1991.21. Siegal T, Lossos A and <strong>Pfeffer</strong> MR.Leptomeningeal metastases: analysis <strong>of</strong> 31 patients with sustained <strong>of</strong>f-therapy responsefollowing combined-modality therapy.Neurology 44:1463-1469, 1994.22. Siegal T and <strong>Pfeffer</strong> MR.Radiation induced changes in the pr<strong>of</strong>ile <strong>of</strong> spinal cord serotonin, prostaglandin synthesis, andvascular permeability.Int J Radiat Oncol Biol Phys 31:57-64, 1995.23. Fiorini AB, Goldin E, Valero JL, Bloom A, Beyar M, <strong>Pfeffer</strong> MR, & Globerman O.Expandable metal coil stent for treatment <strong>of</strong> broncho–esophageal fistula.Gastroint Endosc 42:81-83, 1995.24. Gorodetsky R, Mou X, <strong>Pfeffer</strong> MR, Peretz T, Levy-Agababa F & Vexler AM.
<strong>Dr</strong> <strong>Raphael</strong> <strong>Pfeffer</strong> <strong>CV</strong> 4Sub-additive effect <strong>of</strong> the combination <strong>of</strong> radiation and cisplatin in cultured murine and humancell lines.Isr J Med Sci 31:95-100, 1995.25. Krausz Y, <strong>Pfeffer</strong> MR, Glaser B & Lafair J.Somatostatin-receptor scintigraphy <strong>of</strong> subcutaneous and thyroid metastases from bronchialcarcinoid.J Nucl Med 37:1537-1539, 1996.26. Siegal T. <strong>Pfeffer</strong> MR, Meltzer A, Shezen E, Nimrod A, Ezov N & Ovadia H.Cellular and secretory mechanisms related to delayed radiation-induced microvesseldysfunction in the spinal cord <strong>of</strong> rats.Int J Radiat Oncol Biol Phys 36:649-659, 1996.27. Talmi YP, Waller A, Bercovici M, Horowitz Z, <strong>Pfeffer</strong> MR, Adunski A & Kronenberg J.Pain experienced by patients with terminal head and neck carcinoma.Cancer 80:1117-1123, 1997.28. Talmi YP, Mardinger O, Horowitz Z, Yahalom R, Wolf M, Peleg M, <strong>Pfeffer</strong> MR, Teicher S & Kronenberg Y.Incidence <strong>of</strong> secretory otitis media following maxillectomy.Oral Surg Oral Med Oral Pathol Oral Radiol Endod 86:524-528, 1998.29. <strong>Pfeffer</strong> M.R, AlEzra D, G<strong>of</strong>fman J, & Spiegelman R.Single fraction stereotactic radiation for base <strong>of</strong> skull lesions.Radiosurgery 3:220-226, 1999.30. Talmi YP, Horowitz Z, <strong>Pfeffer</strong> MR, Stolik-Dollberg OC, Shoshani Y, Peleg M, Kronenberg J.Pain in the neck after neck dissection.Otolaryngol Head Neck Surg;;123:302-6, 2000.31. Stemmer S. M., <strong>Pfeffer</strong> M. R, Rizel S, Hardan I, G<strong>of</strong>fman J, Gezin A, Noiman A, Kitsios P, Alezra D, & BrennerH.Feasibility and Low Toxicity <strong>of</strong> Early Radiotherapy Following High Dose Chemotherapy andAutologous Stem Cell Transplantation For High–Risk Stage II-III and Locally Advanced BreastCancer.Cancer. 19:1983-1991, 2001.32. Spiegelmann R, G<strong>of</strong>man J, Alezra D, <strong>Pfeffer</strong> R..Radiosurgery for acoustic neurinomas (vestibular schwannomas).Isr Med Assoc J. 1:8-13, 1999.33. Paltiel O, Avitzour M, Peretz T, Cherny N, Kaduri L, <strong>Pfeffer</strong> MR, Wagner N & Soskolne V.Determinants <strong>of</strong> the use <strong>of</strong> complementary therapies by cancer patients.J Clin Oncol. 19: 2439-2448, 2001.34. Spiegelman R, Lidar Z, Goman J, Alezra D, Hadani M, & <strong>Pfeffer</strong> MR.Linear accelerator radiosurgery for vestibular schwannoma.J Neurosurg 94:7-13, 2001.35. Mardor Y, Roth Y, Lidar Z, Jonas T, <strong>Pfeffer</strong> R, Maier S E, Faibel M, Nass D , Hadani M, Orenstein A, Cohen J S,and Ram Z.Monitoring Response to Convection-Enhanced Taxol Delivery in Brain Tumor Patients UsingDiffusion Weighted MRI.
<strong>Dr</strong> <strong>Raphael</strong> <strong>Pfeffer</strong> <strong>CV</strong> 5Cancer Research 61:4971-4973, 2001.36. Talmi Y P, Horowitz Z, Bedrin L, Wolf M, Chaushu G, Kronenberg J, <strong>Pfeffer</strong> M R.Quality <strong>of</strong> life <strong>of</strong> nasopharyngeal carcinoma patients.Cancer; 94:1012-1017, 2002.37. Cohen ZR, Hassenbusch SJ, Maor MH, <strong>Pfeffer</strong> RM, Ram Z.Intractable vomiting from glioblastoma metastatic to the fourth ventricle: Three case studies.Neuro-oncol 4:129-133, 2002.38. Bolla M, Collette L, Gonzalez D, Warde P, Dubois JB, Miriman<strong>of</strong>f R-O, Storme G, Bernier J, Kuten A, SternbergC, Mattelaer J, Torecilla L, <strong>Pfeffer</strong> MR, Cutajar CL, Zurlo A, Pierart M.Immediate androgen suppression with external irradiation improves survival in patients withlocally advanced prostate cancer. Long term results <strong>of</strong> an EORTC phase III randomized trial.Lancet 360:103-108, 2002.39. Talmi Y P, Wolf M, Horowitz Z, Bedrin L, Kronenberg J <strong>Pfeffer</strong> M R.Smoking induced squamous cell cancer <strong>of</strong> the nose.Archives <strong>of</strong> Envir Health 57:422-4, 2002.40. Spiegelmann, R, Nissim O, Menhel J, Alezra D, <strong>Pfeffer</strong> MR.Linear accelerator radiosurgery for meningiomas in and around the cavernous sinus.Neurosurgery.; 51:1373-80, 2002.41. Mardor Y, <strong>Pfeffer</strong> MR*, Spiegelmann R, Roth Y, Maier SE, Nissim O, Berger R, Glicksman A, Baram J,Orenstein A, Cohen J S and Tichler T.Early Detection <strong>of</strong> Response to Radiation Therapy in Patients with Brain Malignancies UsingConventional and High b-value Diffusion Weighted MRI.J Clin Oncol 21:1094-1100, 2003.42. Stemmer S M, Rizel S, Hardan I, Adamo A, Noiman A, G<strong>of</strong>fman J, Brenner HJ and <strong>Pfeffer</strong> M R.The role <strong>of</strong> internal mammary lymph node radiation in high risk stage II-IIIa breast cancerpatients. A prospective sequential non-randomized study.J Clin Oncol 21:2713-8. 2003.43. Margalit O, Eisenbach L, Amariglio N, Kaminski N, Harmelin A, <strong>Pfeffer</strong> R, Shohat M, Rechavi G, Berger R.Overexpression <strong>of</strong> a set <strong>of</strong> genes, including WISP-1, common to pulmonary metastases <strong>of</strong>both mouse D122 Lewis lung carcinoma and B16-F10.9 melanoma cell lines.Br J Cancer. 89:314-319. 2003/44. Zippel D, Siegelmann-Danieli N, Ayalon S, Kaufman B, <strong>Pfeffer</strong> R, Zvi Papa M..Delayed breast cellulitis following breast conserving operation.Eur J Surg Oncol. 29:327-30. 2003.45. Stemmer SM, Hardan I, Raz H, Adamou AK, Inbar M, Gottfried M, Merrick Y, Cohen Y, Sulkes A, Ben-Baruch N,<strong>Pfeffer</strong> R, Brenner HJ, Rizel S..Adjuvant treatment <strong>of</strong> high-risk stage II breast cancer with doxorubicin followed by high-dosechemotherapy and autologous stem-cell transplantation: a single-institution experience with132 consecutive patients.Bone Marrow Transplant. 31:655-61, 2003.46. Keidan I, Perel A, Shabtai E, <strong>Pfeffer</strong> RM.
<strong>Dr</strong> <strong>Raphael</strong> <strong>Pfeffer</strong> <strong>CV</strong> 6Children undergoing repeated exposures for radiation therapy do not develop tolerance toProp<strong>of</strong>ol: Clinical and bispectral Index (BIS) data.Anesthesiology; 100;251-254, 2004.47. Mardor Y, Roth Y, Ochershvilli A, Spiegelmann R, Tichler T, Daniels D, Maier SE, Nissim O, Ram Z, Baram J,Orenstein A, <strong>Pfeffer</strong> R.Pretreatment prediction <strong>of</strong> brain tumors' response to radiation therapy using high b-valuediffusion-weighted MRI.Neoplasia; 6:136-42, 2004.48. Mardor Y, Roth Y, Daniels D, Ochershvilli A, <strong>Pfeffer</strong> R, Orenstein A, Nissim O, Baram J, Dinstein D, Gordon G,Tichler T, and Spiegelmann R.The application <strong>of</strong> MRI complexity analysis for pre-treatment prediction <strong>of</strong> brain tumorresponse to radiation therapy and radiosurgery- feasibility demonstration.Cancer Therapy Vol 2, 77-84, 2004.49. Lidar Z, Mardor Y, Jonas T, <strong>Pfeffer</strong> R, Faibel M, Nass D, Hadani M, Ram Z.Convection-enhanced delivery <strong>of</strong> paclitaxel for the treatment <strong>of</strong> recurrent malignant glioma: aphase I/II clinical study.J Neurosurg. 100:472-9, 2004.50. Kundel Y, <strong>Pfeffer</strong> R, Lauffer M, Ramon J, Catane R, Symon Z.Salvage prostatic fossa radiation therapy for biochemical failure after radical prostatectomy:the Sheba experience.Isr Med Assoc J.6:329-31, 2004.51. <strong>Pfeffer</strong> MR, Rabin T, Tsvang L, G<strong>of</strong>fman J, Rosen N, Symon Z.Orbital lymphoma: Is it necessary to treat the entire orbit?Int J Radiat Oncol Biol Phys. 60:527-30, 2004.52. Zmora O, Dasilva GM, Gurland B, <strong>Pfeffer</strong> R, Koller M, Nogueras JJ, Wexner SD.Does rectal wall tumor eradication with preoperative chemoradiation permit a change in theoperative strategy?Dis Colon Rectum. 47:1607-12, 2004.53. Paltiel O, Marzec-Boguslawska A, Soskolne V, Massalha S, Avitzour M, <strong>Pfeffer</strong> R, Cherny N & Peretz T.Use <strong>of</strong> tranquilizers and sleeping pills among cancer patients is associated with a poorerquality <strong>of</strong> life.Quality <strong>of</strong> Life Research 13:1699-1706, 2004.54. <strong>Pfeffer</strong> MR, Kundel Y, Zehavi M, Catane R, Koller M, Zmora O, Alkayam R & Symon Z.A Phase I study <strong>of</strong> oral UFT given concomitantly with standard pre-operative radiotherapy for rectal cancer. Isr MedAssoc J.6:595-598, 2004.55. Yakirevitch A , Talmi YP, Baram Y, Weitzen R, & <strong>Pfeffer</strong> MR.Effects <strong>of</strong> cisplatin on olfactory function in cancer patients.Br J Cancer. 92:1611-1613, 2005.(56. Talmi YP, Yakirevitch A, Migirov L, Horowitz Z, Bedrin L, Simon Z, <strong>Pfeffer</strong> MR.
<strong>Dr</strong> <strong>Raphael</strong> <strong>Pfeffer</strong> <strong>CV</strong> 8Am J Clin Oncol. 2007; 30(4):389-94.68. Kundel Y, Brenner B, Symon Z, Oberman B, Sadezki S, Koller M, Catane R, <strong>Pfeffer</strong> R.A phase II study <strong>of</strong> oral UFT and leucovorin concurrently with pelvic irradiation as neoadjuvantchemoradiation for rectal cancer.Anticancer Res. 2007;27(4C):2877-80.69. Agemy L, Harmelin A, Waks T, Leibovitch I, Rabin T, <strong>Pfeffer</strong> M. R., and Eshhar Z.Irradiation Enhances the Metastatic Potential <strong>of</strong> Prostatic Small Cell Carcinoma Xenografts.Prostate; 2008;68:530-539.70. Kopelman D, Inbar Y, Hanannel A, <strong>Pfeffer</strong> RM, Dogadkin O, Freundlich D, Liberman B, Catane R.Magnetic Resonance guided Focused Ultrasound Surgery. Ablation <strong>of</strong> S<strong>of</strong>t Tissue at Bone –Muscle Interface in a Porcine Model. European Journal <strong>of</strong> ClinicalInvestigation, 2008;38(4):268-75.71. Levin D, Menhel J. Alezra D, Symon Z, and <strong>Pfeffer</strong> MR.IMRT vs. 3D non-coplanar treatment plans for maxillary sinus tumors: a new tool forquantitative evaluation. Medical Dosimetry 2008, 33(4):275-81.72. Levin D, Menhel J, Rabin T, <strong>Pfeffer</strong> MR, and Symon Z.Dosimetric comparison <strong>of</strong> Tandem and Ovoids vs. Tandem and Ring for intracavitarygynecologic applications. Medical Dosimetry 2008, 33(4):315-20.73. Kundel Y, Levitt M, Oberman B, Sadezki S, Tichler T, Symon Z, Catane R, <strong>Pfeffer</strong> R and Brenner B.Adjuvant chemotherapy and whole abdominal irradiation for gastric carcinoma. Tumori 2008, 94(4):469-73.74. Mendlovic S, Symon Z, Kundel Y, Rabin T, Catane R, <strong>Pfeffer</strong> R.Three-dimensional conformal radiation therapy concurrent with full dose Gemcitabine forlocally advanced inoperable pancreatic cancer. Harefuah. 2008;147:384-7, 480.75. Varda-Bloom N, Hodish I, Shaish A, Greenberger S, Tal R, Feder B, Roitelman J, Breitbart E, Bangio L,Barshack I, <strong>Pfeffer</strong> R, Harats D.Specific induction <strong>of</strong> tumor neovasculature death by modified murine PPE-1 promoter armedwith HSV-TK. Pathobiology 2008;75:346-55.76. Gluck I, Simon A, Catane R, <strong>Pfeffer</strong> R, Schachter J, Rechavi G, Bar J.Germline analysis <strong>of</strong> thymidine/guanidine polymorphism at position 309 <strong>of</strong> the Mdm2 promoterin malignant melanoma patients.Melanoma Research. 19:199-202, August 2009.77. Hodish I, Tal R, Shaish A, Varda-Bloom N, Greenberger S, Rauchwerger A, Breitbart E, Bangio L, Ben-ShushanD, <strong>Pfeffer</strong> R, Feder B, Waitsman A, Barshack I, Goldberg I, Mazaki-Tovi S, Peled M, Harats D.Systemic administration <strong>of</strong> radiation-potentiated anti-angiogenic gene therapy against primaryand metastatic cancer based on transcriptionally controlled HSV-TK. Cancer Biol Ther.2009;8:424-32.78. Grinberg-Rashi H, Ofek E, Perelman M, Skarda J, Yaron P, Jacob-Hirsch J, Amariglio N, Krupsky M, SimanskyDA., Ram Z, <strong>Pfeffer</strong> R, Galernter I, Steinberg DM., Ben-Dov I, Rechavi G, Izraeli S.The expression <strong>of</strong> three genes in primary non-small cell lung cancer is associated withmetastatic spread to the brain.. Clinical Cancer Research 2009 Mar 1;15(5):1755-61.79. Liberman B, Gianfelice D, Inbar Y, Beck A, Rabin T, Shabshin N, Chander G, Hengst S, <strong>Pfeffer</strong> R, Chechick A,Hanannel A, Dogadkin O, Catane R.
<strong>Dr</strong> <strong>Raphael</strong> <strong>Pfeffer</strong> <strong>CV</strong> 9Pain Palliation in Patients with Bone Metastases Using MR-Guided Focused UltrasoundSurgery: A Multicenter Study.Ann Surg Oncol. 2009 Jan;16(1):140-680. Giro C, Berger Bölke BE, Ciernik F, Duprez F, Locati L, Maillard S, Ozsahin M, <strong>Pfeffer</strong> R., Robertson A G,Langendijk J.A., Budach W.High rate <strong>of</strong> severe radiation dermatitis during radiation therapy with concurrent cetuximab inhead and neck cancer. Results <strong>of</strong> a survey in EORTC institutes. Radiother Oncol. 2009Feb;90(2):166-71.81. Spiegelmann R, Cohen ZR, Nissim O, Alezra D, <strong>Pfeffer</strong> R.Cavernous sinus meningiomas: a large LINAC radiosurgery series. J Neurooncol.2010;98(2):195-202.82. Symon Z, Tsvang L, Wygoda M, Ben-Yoseph R, Corn BW, Poortmans P, Portnoy O, <strong>Pfeffer</strong> MR.An Interobserver Study <strong>of</strong> Prostatic Fossa Clinical Target Volume Delineation in ClinicalPractice: Are Regions <strong>of</strong> Recurrence Adequately Targeted? Am J Clin Oncol. 2011;34:145-9.83. Bolla M, Van Tienhoven G, Warde P, Dubois JB, Miriman<strong>of</strong>f RO, Storme G, Bernier J, Kuten A, Sternberg C,Billiet I, Torecilla JL, <strong>Pfeffer</strong> R, Cutajar CL, Van der Kwast T, Collette L.External irradiation with or without long-term androgen suppression for prostate cancer with highmetastatic risk: 10-year results <strong>of</strong> an EORTC randomised study. Lancet Oncol. 2010;11:1066-73.84. Postoperative chemoradiation for resected gastric cancer –Is the Macdonald regimen Tolerable? A retrospectivemulti-institutional study.Kundel Y, Purim O, Idelevich E, Lavrenkov K, Man S, Kovel S, Karminsky N, <strong>Pfeffer</strong> RM,Nisenbaum B, Fenig E, Sulkes A, Brenner B. Radiat Oncol. 2011; 6:12785. Stiebel-Kalish H, Reich E, Gal L, Rappaport ZH, Nissim O, <strong>Pfeffer</strong> R, Spiegelmann R.Visual Outcome in Meningiomas Around Anterior Visual Pathways Treated With LinearAccelerator Fractionated Stereotactic Radiotherapy. Int J Radiat Oncol Biol Phys. 2011 Feb 5.[Epub ahead <strong>of</strong> print]86. Urban D, Mishra M, Onn A, Dicker AP, Symon Z, <strong>Pfeffer</strong> MR, Lawrence YRRadiotherapy Improves Survival in Unresected Stage I-III Bronchoalveolar Carcinoma..Int JRadiat Oncol Biol Phys. 2012 Mar 13. .
Change language